Free Trial

Arvin Capital Management LP Grows Stake in Rentokil Initial plc (NYSE:RTO)

Rentokil Initial logo with Business Services background

Arvin Capital Management LP increased its stake in Rentokil Initial plc (NYSE:RTO - Free Report) by 33.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 173,600 shares of the company's stock after purchasing an additional 43,600 shares during the quarter. Rentokil Initial comprises about 1.2% of Arvin Capital Management LP's holdings, making the stock its 23rd largest position. Arvin Capital Management LP's holdings in Rentokil Initial were worth $4,396,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of RTO. Cape Investment Advisory Inc. increased its holdings in shares of Rentokil Initial by 65.2% in the 4th quarter. Cape Investment Advisory Inc. now owns 1,505 shares of the company's stock worth $38,000 after buying an additional 594 shares during the last quarter. CENTRAL TRUST Co lifted its stake in Rentokil Initial by 15,208.3% during the fourth quarter. CENTRAL TRUST Co now owns 1,837 shares of the company's stock worth $47,000 after purchasing an additional 1,825 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of Rentokil Initial by 486.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,942 shares of the company's stock worth $49,000 after purchasing an additional 1,611 shares in the last quarter. Cromwell Holdings LLC bought a new position in shares of Rentokil Initial during the 4th quarter valued at about $59,000. Finally, Blue Trust Inc. lifted its position in Rentokil Initial by 140.4% in the 4th quarter. Blue Trust Inc. now owns 2,402 shares of the company's stock worth $60,000 after buying an additional 1,403 shares during the last quarter. 9.91% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Rentokil Initial in a research note on Friday, March 7th. Three equities research analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy".

Check Out Our Latest Analysis on Rentokil Initial

Rentokil Initial Trading Up 1.2 %

RTO stock traded up $0.27 during midday trading on Friday, hitting $23.03. The company had a trading volume of 431,637 shares, compared to its average volume of 765,727. The stock has a market cap of $11.63 billion, a price-to-earnings ratio of 15.25, a PEG ratio of 7.95 and a beta of 1.07. Rentokil Initial plc has a 52 week low of $19.60 and a 52 week high of $34.07. The company has a current ratio of 1.04, a quick ratio of 0.96 and a debt-to-equity ratio of 0.75. The stock's 50 day moving average price is $22.98 and its 200 day moving average price is $24.42.

Rentokil Initial Dividend Announcement

The company also recently declared a semi-annual dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 4th will be given a dividend of $0.3825 per share. The ex-dividend date of this dividend is Friday, April 4th. This represents a yield of 2.4%. Rentokil Initial's payout ratio is currently 43.71%.

About Rentokil Initial

(Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

Featured Stories

Institutional Ownership by Quarter for Rentokil Initial (NYSE:RTO)

Should You Invest $1,000 in Rentokil Initial Right Now?

Before you consider Rentokil Initial, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.

While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines